XML 39 R19.htm IDEA: XBRL DOCUMENT v2.4.0.8
Commitments and Contingencies (Tables)
 6 Months Ended
Jun. 30, 2014
Commitments and Contingencies [Abstract]  
Summary of milestone payment

 

Milestones Payments 
     
(1) when Company initiates a Phase I Clinical Trial of a licensed product $750,000 
(2) when Company initiates a Phase II Clinical Trial of a licensed product  750,000 
(3) when Company initiates a Phase III Clinical Trial of a licensed product  1,500,000 
(4) Biological License Application filing with U.S. FDA  1,750,000 
(5) First commercial sale  1,500,000 
(6) after the first $10,000,000 in net sales  1,500,000